Logo Logo

Publications by Pujade-Lauraine, E.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 4.

Journal article

Ray-Coquard, I.; Trama, Annalisa; Seckl, M. J.; Fotopoulou, C.; Pautier, P.; Pignata, S.; Kristensen, G.; Mangili, G.; Falconer, H.; Massuger, L.; Sehouli, J.; Pujade-Lauraine, E.; Lorusso, D.; Amant, F.; Rokkones, E.; Vergote, I.; Ledermann, J. A.; Schubert-Fritschle, Gabriele (January 2019): Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. In: European Journal of Surgical Oncology, Vol. 45, No. 1: pp. 67-74

Trillsch, F.; Mahner, S.; Hilpert, F.; Davies, L.; García-Martínez, E.; Kristensen, G.; Savarese, A.; Vuylsteke, P.; Los, M.; Zagouri, F.; Gladieff, L.; Sehouli, J.; Lee, C. Khoon; Gebski, V.; Pujade-Lauraine, E. (2016): Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial. In: Annals of Oncology, Vol. 27, No. 9: pp. 1733-1739

Lindemann, K.; Kristensen, G.; Mirza, M. R.; Davies, L.; Hilpert, F.; Romero, I.; Ayhan, A.; Burges, A.; Rubio, M. J.; Raspagliesi, F.; Huizing, M.; Creemers, G.-J.; Lykka, M.; Lee, C. K.; Gebski, V.; Pujade-Lauraine, E. (2016): Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial. In: Annals of Oncology, Vol. 27, No. 8: pp. 1505-1510

Trillsch, F.; Mahner, S.; Hilpert, F.; Davis, L.; Garcia, E.; Kristensen, G.; Savarese, A.; Vuylsteke, P.; Loos, M.; Zagouri, F.; Gladieff, L.; Sehouli, J.; Lee, C. K.; Gebski, V.; Pujade-Lauraine, E. (2016): Prognostic and predictive values of primary vs secondary platinum resistance for bevacizumab treatment in platinum-resistant ovarian cancer in the AURELIA trial. In: Oncology Research and Treatment, Vol. 39: p. 93

This list was generated on Sat Sep 21 16:31:25 2019 CEST.